Henry Schein, Inc. Announces Acquisition Of Bond Pharmaceutical And Medical Supply Company

Business Wire, March 21, 1996

MELVILLE, N.Y.--(BUSINESS WIRE)--March 21, 1996--Henry Schein, Inc. (Nasdaq:HSIC) today announced the acquisition of Phoenix, Arizona-based Bond Pharmaceutical and Medical Supply Company. Bond, which is a leading direct marketer of vaccines to the office-based physician market with 1995 sales of vaccines and medical supplies of approximately $9 million, will become part of Henry Schein's Medical Group.

Bond is also one of the nation's largest vaccine distributors under the federal and state sponsored Vaccine for Children program and, in addition to its sales, receives distribution fees as the exclusive distributor of children's vaccines to approximately 5,000 physicians under this program in Arizona, California, Missouri, Oregon and Utah.

In announcing this acquisition, Stanley Bergman, Henry Schein's Chairman, President and CEO said, "This transaction complements our approach of completing strategic acquisitions to gain market share in the office-based physician market. Bond's expertise in the area of vaccine distribution combined with our low cost distribution system, integrated marketing approach and commitment to excellent customer service will enhance our ability to focus on this important niche of the medical market and open up a new audience for our existing products and services."

Henry Schein, Inc. is the largest direct marketer of healthcare products and services to office-based healthcare practitioners, including dental practices and laboratories, physician practices and veterinary clinics. The Company, recognized for its excellent customer service and low prices, serves more than 200,000 customers worldwide.

CONTACT: Henry Schein, Inc.

Steven Paladino, 516/843-5500

or

Morgen-Walke Associates

Investor Relations: Robert Jones/

Sue Rodney/Caroline Babbitt

Press: Michelle Zawrotny, 212/850-5600